Doliente, Luzviminda B.
HRN: 00-57-44 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2024
CEFTRIAXONE 1G (VIAL)
08/25/2024
09/01/2024
IV
2g
OD
CAP MR ;UTI
Waiting Final Action
08/28/2024
CEFIXIME 200MG (CAP)
08/28/2024
09/04/2024
PO
200mg
Q12
CAP MR
Waiting Final Action